4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-001467
Chief Executive Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2019-01-01 | Grant or award | +600,000 | 2,142,455 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…